McKinley Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-220,277
Closed -$32.1M 392
2017
Q3
$32.1M Buy
220,277
+183,577
+500% +$25M 1.31% 27
2017
Q2
$4.77M Sell
36,700
-7,292
-17% -$893K 0.18% 91
2017
Q1
$5.47M Sell
43,992
-48
-0.1% -$5.74K 0.2% 79
2016
Q4
$5.1M Sell
44,040
-18,139
-29% -$2.02M 0.2% 94
2016
Q3
$6.5M Buy
62,179
+5,785
+10% +$626K 0.23% 111
2016
Q2
$5.56M Sell
56,394
-64
-0.1% -$6.62K 0.27% 119
2016
Q1
$5.65M Sell
56,458
-251
-0.4% -$25.8K 0.27% 104
2015
Q4
$6.79M Sell
56,709
-3,438
-6% -$398K 0.31% 85
2015
Q3
$6.51M Sell
60,147
-98
-0.2% -$12.2K 0.32% 90
2015
Q2
$6.97M Sell
60,245
-3,474
-5% -$397K 0.3% 98
2015
Q1
$7.35M Sell
63,719
-152
-0.2% -$18.2K 0.29% 97
2014
Q4
$7.14M Sell
63,871
-225
-0.4% -$23.7K 0.29% 104
2014
Q3
$6.08M Sell
64,096
-11,228
-15% -$1.01M 0.27% 102
2014
Q2
$6.47M Sell
75,324
-800
-1% -$60.8K 0.27% 97
2014
Q1
$5.31M Buy
76,124
+406
+0.5% +$32.2K 0.22% 113
2013
Q4
$6.4M Buy
75,718
+73,512
+3,332% +$5.82M 0.25% 96
2013
Q3
$170K Buy
+2,206
New +$155K 0.01% 337

Other funds holding CELG

McKinley Capital Management's CELG Position: Q4 2017 in Review

McKinley Capital Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 220,277 shares — an estimated $32.1M sold.

McKinley Capital Management first reported a position in CELG in Q3 2013 and held it in 17 quarters. The position peaked at $32.1M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • McKinley Capital Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • McKinley Capital Management sold 220,277 Celgene Corp shares in Q4 2017, an estimated $32.1M.
  • McKinley Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 17 quarters.
  • McKinley Capital Management's Celgene Corp position peaked at $32.1M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on McKinley Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.